Merck

Merck to cut 12K jobs

Friday, July 29, 2011 12:55 PM

Merck plans to slash thousands more jobs by late 2015 to wring out additional annual cost savings of up to $1.5 billion that can be plowed back into research and deal making, according to Reuters.

More... »

Icon acquires Firecrest Clinical, adding portal technology to boost site quality while reducing errors and costs

Monday, July 25, 2011 08:02 AM

As large pharmaceutical companies scrutinize the pack of mid- and top-tier CROs to determine who wins the coveted strategic-partnership agreements, there’s a mad scramble among CROs to differentiate themselves from one another and stand out as efficient, high quality, exciting and deserving.

More... »

Pfizer to open research center in San Francisco’s Mission Bay

Friday, July 22, 2011 01:28 PM

Boosting Mission Bay's goal of becoming a hub for cutting-edge biotech, Pfizer has plans to establish a research center at the 303-acre former industrial site overlooking San Francisco Bay, according to the San Francisco Chronicle.

More... »

EMD Serono names Hoyes president

Wednesday, July 20, 2011 11:33 AM

EMD Serono, an affiliate of Germany-based Merck, has named James Hoyes president. He will be responsible for driving the strategic direction of the U.S. commercial organization as well as managing the day-to-day business of the U.S. affiliate of Merck. Hoyes will also serve as a member of the executive management board for Merck Serono, the global pharmaceuticals division of Merck.

More... »

Merck continues plans to cut jobs

Friday, July 15, 2011 10:07 AM

Last year, Merck disclosed plans to save up to $3.5 billion by closing numerous research sites and manufacturing plants and eliminate roughly 15,000 jobs by 2012, or roughly 10% of the total headcount including the thousands of employees who were part of the 2009 acquisition of Schering-Plough. Before that deal, Merck employed about 53,000 people, reported Pharmalot.

More... »

Gilead to allow generic AIDS drugs through Medicines Patent Pool

Wednesday, July 13, 2011 10:46 AM

Gilead Sciences will allow some of its AIDS drugs to be made by generic manufacturers, potentially increasing their availability in poor countries, particularly in Africa, according to the Associated Press.

More... »

Lilly pitches plan to overcome key patent losses

Friday, July 8, 2011 10:15 AM

Eli Lilly, only months away from losing patent protection for its top-selling drug, told investors the keys to overcoming this and other patent losses lie in its labs and emerging markets including China, according to Mercury News.

More... »

Merck Serono changes R&D organizational structure

Thursday, July 7, 2011 02:02 PM

Merck Serono, a division of Merck of Darmstadt, Germany, is putting a new organizational structure for research and development into effect. Two dedicated groups, focusing on different stages of pharmaceutical innovation (pre- and post- proof-of-concept), will be created as a first step in redesigning Merck Serono's R&D model.

More... »

Merck strategically shedding compounds

Thursday, July 7, 2011 10:05 AM

Almost as soon as the Merck and Schering-Plough pipelines were combined in late 2009, Merck had to go through all of its compounds and decide which to shed, according to Chemical & Engineering News.

More... »

MS research funding awards given

Wednesday, July 6, 2011 10:13 AM

Merck Serono and Fast Forward announced the second group of recipients to receive funding designed to speed research advances in high potential areas of multiple sclerosis (MS) research.

More... »